Clinical trials
Completed Phase 4 Inflammation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
155 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 9 |
| 2007 | 6 |
| 2008 | 12 |
| 2009 | 8 |
| 2010 | 14 |
| 2011 | 11 |
| 2012 | 10 |
| 2013 | 11 |
| 2014 | 10 |
| 2015 | 9 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 155 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 3 |
| Bausch & Lomb Incorporated | 3 |
| Changi General Hospital | 3 |
| Emory University | 3 |
| University Of Perugia | 3 |
| University of California, San Francisco | 3 |
| University of Padova | 3 |
| University of Pennsylvania | 3 |
| Coordinación de Investigación en Salud, Mexico | 2 |
| Gulhane School of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 155 |
| Diabetes Mellitus, Type 2 | 11 |
| Atherosclerosis | 10 |
| Kidney Failure, Chronic | 10 |
| Pain | 10 |
| Insulin Resistance | 9 |
| Obesity | 8 |
| Cardiovascular Diseases | 7 |
| Coronary Artery Disease | 6 |
| Diabetes Mellitus | 6 |
Trials
Showing 1 to 25 of 155. Each trial links to its page on Pharma Observatory.
55 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.